Global Surgical Staplers Strategic Business Report 2024: Market to Reach $6.6 Billion by 2030, Manual Segment to Account for $4.6 Billion – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Surgical Staplers: Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s... Read more.
Former SAP EVP Max Wessel joins Degreed as President
Industry veteran joins Degreed to further its mission of making skills, not 4-year credentials, the currency of work. PLEASANTON, Calif.–(BUSINESS WIRE)–Degreed,... Read more.
Charles River Associates (CRA) Reports Fourth-Quarter and Full-Year 2023 Financial Results
Broad-based Contributions Drive Record Revenue in Fiscal 2023 Fourth Quarter Revenue Increases 11.5% Year Over Year Board Expands Share Repurchase Authorization... Read more.
Forbes Names Alliant Insurance Services One of America’s Best Employers for 2024
Independent survey by Forbes and Statista, Inc. places Alliant among the nation’s top large employers IRVINE, Calif.–(BUSINESS WIRE)–#AlliantInsurance—Alliant... Read more.
Mental Health Leaves of Absence Surge, Increasing 33% Over Prior Year
ComPsych Data Shows Millennial Women Accounted for a Third of All Mental Health Related Leaves of Absences in 2023 CHICAGO–(BUSINESS WIRE)–ComPsych®... Read more.
In Sickness. Men and the Culture of Caregiving Launches as Podcast Sharing Powerful Stories of Male Caregivers
Episode One Featuring Conversation with Incoming BIO CEO John Crowley as he shares his Story of Hope and Courage In Sickness co-hosted by biotech industry veterans... Read more.
Endologix Initiates Percutaneous Transmural Arterial Bypass (PTAB)1 Post-Market Study
IRVINE, Calif.–(BUSINESS WIRE)–Endologix LLC, a privately held, global medical device company dedicated to providing disruptive therapies for the interventional... Read more.
Natera to Participate in March Investor Conferences
AUSTIN, Texas–(BUSINESS WIRE)–Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DNA testing, today announced that it will participate in the... Read more.
Destroy Duchenne selects DNA Nanobots as Partner to Develop Non-Viral Gene Delivery Solution for Duchenne Muscular Dystrophy
DMD patient and advocate Elijah Stacy’s non-profit foundation chooses a targeted dystrophin gene therapy approach using DNA nanoparticles to overcome limitations... Read more.
AppLovin Announces Pricing of Secondary Public Offering of Common Stock and Concurrent Share Repurchase
PALO ALTO, Calif.–(BUSINESS WIRE)–AppLovin Corporation (NASDAQ: APP) (“AppLovin” or the “Company”), a leading marketing platform, today announced... Read more.